Insider Transactions in Q1 2022 at Cardiovascular Systems Inc (CSII)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price | 
|---|---|---|---|---|---|
| 
            Feb 23                          
            2022                          
           | Erik Paulsen Director | 
              BUY
             
                Open market or private purchase
             | Direct | 
              500
              +41.67%
           | 
              $9,500              
              $19.05 P/Share              
           | 
| 
            Feb 08                          
            2022                          
           | Jeffrey S. Points Chief Financial Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +4.9%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Jeffrey S. Points Chief Financial Officer | 
              BUY
             
                Open market or private purchase
             | Direct | 
              2,000
              +1.94%
           | 
              $36,000              
              $18.2 P/Share              
           | 
| 
            Feb 08                          
            2022                          
           | Alexander Rosenstein General Counsel & Corp. Sec. | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +5.16%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Sandra Sedo Chief Compliance Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +6.31%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Ryan Egeland Chief Medical Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +6.71%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | John M. Hastings VP Manufacturing & Operations | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +9.01%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | David Whitescarver VP of Corp. Dev. and IP | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +7.97%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Stephen J. Rempe Chief Human Resources Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +9.93%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Scott R. Ward Chairman and CEO | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +0.94%
           | 
              -                 
           | 
| 
            Feb 08                          
            2022                          
           | Rhonda J. Robb Chief Operating Officer | 
              BUY
             
                Grant, award, or other acquisition
             | Direct | 
              5,477
              +3.13%
           | 
              -                 
           | 
| 
            Feb 07                          
            2022                          
           | Scott R. Ward Chairman and CEO | 
              BUY
             
                Open market or private purchase
             | Direct | 
              2,500
              +0.44%
           | 
              $45,000              
              $18.52 P/Share              
           | 
| 
            Feb 07                          
            2022                          
           | Rhonda J. Robb Chief Operating Officer | 
              BUY
             
                Open market or private purchase
             | Direct | 
              1,567
              +0.95%
           | 
              $28,206              
              $18.71 P/Share              
           | 
| 
            Feb 07                          
            2022                          
           | Martha Goldberg Aronson Director | 
              BUY
             
                Open market or private purchase
             | Direct | 
              2,500
              +20.0%
           | 
              $45,000              
              $18.43 P/Share              
           |